Skip to main content
. 2020 Nov 18;8(11):513. doi: 10.3390/biomedicines8110513

Figure 7.

Figure 7

Anti-cytotoxic activity of RHB-104 and its major components in Caco-2 monolayer treated with 3% DSS. Trypan blue exclusion assay showing the cytotoxic effects (indicated by red arrows) in DSS-treated Caco-2 monolayers (A), and DSS-treated Caco-2 monolayers with 1.0 μg/mL RHB-104 (B), 0.63 μg/mL CLA (C), and 0.30 μg/mL RIF (D). LDH Activity (E) and GSH activity (F) in DSS-treated Caco-2 monolayers treated with RHB-104 (0, 0.5, 1.0, 2.0 μg/mL), CLA (0, 0.32, 0.63, and 1.26 μg/mL), and RIF (0, 0.15, 0.30, 0.60 μg/mL) for 24 h. * p < 0.05.